Inflammation  >>  Pulmicort Turbuhaler (budesonide dry-powder inhaler)  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Pulmicort Turbuhaler (budesonide dry-powder inhaler) / AstraZeneca
ChiCTR-TRC-12002459: Therapeutic effect of inhaled budesonide (Pulmicort Turbuhaler) on lung inflammatory response to the one lung ventilation

Completed
N/A
60
 
nebulized saline ;nebulized budesonide
Department of ICU, The Affiliated Tumor Hospital, Harbin Medical University; Level of the institution：, NO
lung cancer
 
 

Download Options